• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 GROSHONG NXT CLEARVUE 4F SINGLE-LUMEN BASIC TRAY WITH SAFETY INTRODUCER; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 GROSHONG NXT CLEARVUE 4F SINGLE-LUMEN BASIC TRAY WITH SAFETY INTRODUCER; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS Back to Search Results
Model Number N/A
Device Problem Fluid/Blood Leak (1250)
Patient Problems Chemical Exposure (2570); Skin Inflammation/ Irritation (4545)
Event Date 10/21/2022
Event Type  Injury  
Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of refw4267 showed no other similar product complaint(s) from this lot number.
 
Event Description
It was reported the patient was placed in the left upper arm picc on (b)(6) 2022, and the blood was returned to the patient's left upper arm through two-person aspiration and bolus injection.After intravenous bolus injection of dexamethasone sodium phosphate, intravenous infusion of gastric protection, antiemetic and rehydration was performed, and no oozing fluid was found.At 17:09, chemotherapy with irinotecan was pumped through picc, and the infusion pump controlled the speed to 125ml/h, and no blood or exudate was seen; at 18:00, the nurses found blood exudate in the dressing of the patient, and the infusion was suspended immediately.Irinotecan was found to be the loose joint of the catheter and aircraft wing.The patient's skin was treated and disinfected according to the chemotherapy drug leakage process, and the catheter and aircraft wing connector was re-fixed, picc was stopped, and chemotherapy was suspended.On the 22nd, members of the static therapy team checked the patient's picc again, and confirmed that the leakage of chemotherapy drugs was caused by the loose joint of the aircraft wing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GROSHONG NXT CLEARVUE 4F SINGLE-LUMEN BASIC TRAY WITH SAFETY INTRODUCER
Type of Device
CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
becky garcia
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key15811078
MDR Text Key303793156
Report Number3006260740-2022-05335
Device Sequence Number1
Product Code LJS
UDI-Device Identifier00801741086991
UDI-Public(01)00801741086991
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K034020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2024
Device Model NumberN/A
Device Catalogue Number7617405
Device Lot NumberREFW4267
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/01/2022
Initial Date FDA Received11/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-